WHO issues ALERT for four cough syrups made by India’s Maiden Pharmaceuticals, knows why


New Delhi: The World Health Organization (WHO) issued a medical product warning on Wednesday about four cough and cold syrups manufactured by Maiden Pharmaceuticals Ltd in India. These may be linked to acute kidney injury and 66 deaths among children in The Gambia. The WHO said it was conducting additional investigations with the company and the Indian regulatory authorities. Maiden Pharmaceuticals did not immediately respond to a request for comment from Reuters.

dr. WHO Director General Tedros Adhanom Ghebreyesus said at a press conference: “WHO today issued a medical product warning for four contaminated drugs identified in The Gambia that may have been linked to acute kidney injury and 66 deaths in children. Losing these young lives is beyond heartbreaking to their families. The four drugs are cough and cold syrups manufactured by Maiden Pharmaceuticals Limited, in India.”

Also Read: AIIMS Bilaspur will be known as ‘Green Hospital’; government will promote medical tourism in Himachal: PM Narendra Modi

“WHO is conducting further investigations with the company and regulatory authorities in India. Although the contaminated products have only been discovered so far in The Gambia, they may have been distributed to other countries. The WHO recommends that all countries detect these products and from circulation to prevent further harm to patients,” Ghebreyesus further added.

(Inputs from ANI)





Source link
Zee News

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Adipurush: UP Deputy CM Keshav Prasad Maurya Responds To Controversy, Says ‘Film Needs Correction And…’
Next post India’s wrestling fraternity rues 2026 CWG abolishing sports
Close